HeartSciences (HSCS) Change in Accured Expenses (2021 - 2026)
HeartSciences' (HSCS) quarterly Change in Accured Expenses came in at $220790.0 in Q2 2026, down 15.51% YoY from $261319.0 in Q2 2025, and up 166.06% on a QoQ basis from -$334208.0 in Q4 2025.
HeartSciences (HSCS) Change in Accured Expenses (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has 6 years of Change in Accured Expenses data on file, last reported at $220790.0 in Q2 2026.
- Quarterly Change in Accured Expenses fell 15.51% year-over-year to $220790.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $314619.0 (up 1773.74% YoY) and the FY2026 annual result came in at $121479.0, up 623.48% from the prior year.
- Change in Accured Expenses advanced to $220790.0 in Q2 2026, from -$334208.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $371484.0 in Q2 2022 to a low of -$477475.0 in Q3 2022.
- A 5-year average of $21705.2 and a median of $15744.0 in 2025 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses slumped 997.02% — and 2025, when it soared 472.92%.
- Tracing HSCS's Change in Accured Expenses over 5 years: stood at $247141.0 in 2022, then sank by 126.67% to -$65901.0 in 2023, then plunged by 227.11% to -$215566.0 in 2024, then slumped by 55.04% to -$334208.0 in 2025, then soared by 166.06% to $220790.0 in 2026.
- The last three Change in Accured Expenses figures came in at $220790.0 (Q2 2026), -$334208.0 (Q4 2025), and $166718.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.80 Mn |
| 10 | HeartSciences | 7.06 Mn | 5.36 Mn | - | 220,790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 220,790.00 |
| Apr 30, 2026 | 220,790.00 |
| Oct 31, 2025 | -334,208.00 |
| Oct 31, 2025 | -334,208.00 |
| Jul 31, 2025 | 166,718.00 |
| Jul 31, 2025 | 166,718.00 |
| Apr 30, 2025 | 261,319.00 |
| Apr 30, 2025 | 261,319.00 |
| Jan 31, 2025 | 15,744.00 |
| Jan 31, 2025 | 15,744.00 |
| Oct 31, 2024 | -215,566.00 |
| Oct 31, 2024 | -215,566.00 |
| Jul 31, 2024 | -44,706.00 |
| Jul 31, 2024 | -44,706.00 |
| Apr 30, 2024 | 82,718.00 |
| Apr 30, 2024 | 82,718.00 |
| Jan 31, 2024 | -103,237.00 |
| Jan 31, 2024 | -103,237.00 |
| Oct 31, 2023 | -65,901.00 |
| Oct 31, 2023 | -65,901.00 |